Deep within the world's oceans lurk marine bacteria armed with plastic-munching enzymes, their evolution seemingly sculpted ...

QIAGEN today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free solutions for single-cell research. The ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the third quarter of 2025 and reaffirmed its outlook for solid profitable growth while raising its profitability ...

Qiagen (QGEN) announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a provider of scalable, instrument-free ...

Key market opportunities in oncology clinical trials include personalized treatment demand, advancements in AI-driven ...

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, ...

Gliomas are the most prevalent and aggressive primary brain tumors, characterized by profound tumor heterogeneity, poor prognosis, and limited therapeutic ...

The International Institute of Information Technology (IIIT) Hyderabad has appointed Prof U Deva Priyakumar as its new Dean ...

The emergence of generative artificial intelligence tools has opened new doors for Australia's research community. The Sydney ...

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed withour AI-Immunology™ ...